Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to $6.3 billion.

  • Dexcom's Liabilities and Shareholders Equity fell 222.99% to $6.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $27.9 billion, marking a year-over-year increase of 688.71%. This contributed to the annual value of $6.3 billion for FY2025, which is 222.99% down from last year.
  • Per Dexcom's latest filing, its Liabilities and Shareholders Equity stood at $6.3 billion for Q4 2025, which was down 222.99% from $7.5 billion recorded in Q3 2025.
  • Dexcom's 5-year Liabilities and Shareholders Equity high stood at $7.5 billion for Q3 2025, and its period low was $4.4 billion during Q1 2021.
  • In the last 5 years, Dexcom's Liabilities and Shareholders Equity had a median value of $6.3 billion in 2023 and averaged $5.9 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 7932.92% in 2021, then crashed by 367.48% in 2024.
  • Quarter analysis of 5 years shows Dexcom's Liabilities and Shareholders Equity stood at $4.9 billion in 2021, then grew by 9.29% to $5.4 billion in 2022, then increased by 16.19% to $6.3 billion in 2023, then increased by 3.51% to $6.5 billion in 2024, then dropped by 2.23% to $6.3 billion in 2025.
  • Its Liabilities and Shareholders Equity was $6.3 billion in Q4 2025, compared to $7.5 billion in Q3 2025 and $7.3 billion in Q2 2025.